Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest Aortic valve stenosis Stories

2011-01-04 15:13:00

NATICK, Mass., Jan. 4, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the completion of its acquisition of Sadra Medical, Inc. of Los Gatos, California. The transaction follows the definitive merger agreement announced on November 19, 2010. Under the terms of the agreement, Boston Scientific paid $193 million to acquire the remaining 86 percent of Sadra Medical's equity not already owned by Boston Scientific. Additional payments of up to $193 million are...

2010-12-21 13:23:00

MOUNTAIN VIEW, Calif., Dec. 21 2010 /PRNewswire/ -- El Camino Hospital today announced its first patient implant in the Medtronic CoreValve® U.S. Clinical Trial. El Camino Hospital is one of the first of 40 hospitals across the U.S. to participate in the trial, which is evaluating a revolutionary non-surgical, less-invasive procedure as a treatment alternative to open-heart surgery for patients with severe aortic stenosis. "The Heart and Vascular Institute at El Camino...

2010-11-19 10:58:00

NATICK, Mass. and LOS GATOS, Calif., Nov. 19, 2010 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced the signing of a definitive merger agreement, under which Boston Scientific will acquire Sadra Medical, Inc., a development-stage company in Los Gatos, California. Sadra is developing the first fully repositionable device for percutaneous aortic valve replacement to treat patients with severe aortic stenosis. The agreement calls for an upfront payment of...

2010-10-21 13:36:43

Despite the promising results of the "Placement of Aortic Transcatheter Valves (PARTNER) trial," featured in the Oct. 21 issue of the New England Journal of Medicine, a cardiothoracic surgeon from Boston Medical Center (BMC) believes that surgical aortic-valve replacement should remain the standard treatment of aortic stenosis. In the accompanying editorial, the author argues that Transcatheter aortic-valve implantation (TAVI) should be reserved for patients at inordinately high risk who are...

2010-09-23 12:36:39

Multicenter study of new treatment for patients with severe aortic stenosis published in New England Journal of Medicine and reported at TCT One-year data from the PARTNER clinical trial, published today in the New England Journal of Medicine, demonstrate that transcatheter aortic-valve implantation, compared with standard therapy, resulted in significantly lower rates of death among patients who cannot undergo surgery for aortic stenosis. The results will be presented tomorrow as a Late...

2010-09-23 10:56:00

WASHINGTON, Sept. 23 /PRNewswire/ -- One-year data from the PARTNER clinical trial, published yesterday in the New England Journal of Medicine, demonstrate that transcatheter aortic-valve implantation, compared with standard therapy, resulted in significantly lower rates of death among patients who cannot undergo surgery for aortic stenosis. The results will be presented today as a Late Breaking Trial at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific...

2010-09-22 19:56:35

Implantation of a new bioprosthetic-tissue valve into the hearts of patients who have severe aortic stenosis and are too sick or too old for open-heart surgery has been found to both save lives and improve the quality of those lives, according to a new multicenter study, to be published online at 2 p.m. Pacific time today in the New England Journal of Medicine. The study will also be presented at 8 a.m. Pacific time at the Transcatheter Cardiovascular Therapeutics Conference in Washington,...

2010-09-22 16:01:00

WASHINGTON, Sept. 22 /PRNewswire/ -- One-year data from the PARTNER clinical trial, published today in the New England Journal of Medicine, demonstrate that transcatheter aortic-valve implantation, compared with standard therapy, resulted in significantly lower rates of death among patients who cannot undergo surgery for aortic stenosis. The results will be presented tomorrow as a Late Breaking Trial at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium....

2010-09-14 12:51:30

Study highlights:     * After aortic valve replacement, the size of enlarged hearts shrink faster in women than in men with narrowed aortic valves (aortic stenosis).    * Because of different genetic activity, men develop more fibrous tissue in their hearts, which may explain why women's heart size decreases faster. Heart enlargement caused by narrowed aortic valves regresses faster in elderly women than in men after aortic valve replacement, according to...

2010-05-04 11:17:41

A new study shows that people with a common heart defect may also be more likely to have brain aneurysms. The study is published in the May 4, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology. Up to two percent of the population is born with the heart defect called a bicuspid aortic valve (BAV). The aortic valve allows blood to flow from the heart to the aorta. It normally has three flaps that open and close to regulate blood flow. In...